Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cipla
US Army
Chubb
Queensland Health
Medtronic
Chinese Patent Office
Deloitte
Colorcon

Generated: May 25, 2018

DrugPatentWatch Database Preview

Vinorelbine tartrate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for vinorelbine tartrate and what is the scope of vinorelbine tartrate patent protection?

Vinorelbine tartrate
is the generic ingredient in two branded drugs marketed by Pierre Fabre, Actavis Totowa, Dr Reddys Labs Ltd, Ebewe Pharma, Fresenius Kabi Usa, Hospira, Jiangsu Hansoh Pharm, Mylan Labs Ltd, Teva Pharms Usa, and West-ward Pharms Int, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for vinorelbine tartrate. Four suppliers are listed for this compound.
Pharmacology for vinorelbine tartrate
Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid
Synonyms for vinorelbine tartrate
125317-39-7
C45H54N4O8.2C4H6O6
CAS-125317-39-7
CHEMBL538943
CV0016
DSSTox_CID_27802
DSSTox_GSID_47825
DSSTox_RID_82572
DTXSID5047825
H847
KB-276096
MolPort-003-986-338
Navelbine
NCGC00165966-02
NCGC00263568-01
SCHEMBL4764
TL8000651
Tox21_112271
Tox21_112271_1
Vinorelbine bitartate
vinorelbine ditartate

US Patents and Regulatory Information for vinorelbine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076849-001 Apr 18, 2005 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Ltd VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 202017-001 Sep 12, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pierre Fabre NAVELBINE vinorelbine tartrate INJECTABLE;INJECTION 020388-001 Dec 23, 1994 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076461-001 Dec 11, 2003 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Dow
Covington
Boehringer Ingelheim
US Army
Johnson and Johnson
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.